Search

When's the last time you sequenced the phages in your lab? Have you ever, or are you relying on what someone said they were? You might be like 12/13 phage labs and have secret mixtures masquerading as pure phages. You should sequence your p

Rob Edwards at Flinders University in Australia is hiring a PhD student to study how phages generate targeted mutations for host-range evolution.

Rob Edwards at Flinders University in Australia is hiring a PhD student to study how phages generate targeted mutations for host-range evolution.

Join Evergreen 2025 Virtually! Phagebiotics Research Foundation is excited to announce a virtual attendance option for the 26th Biennial Evergreen International Phage Meeting 📅 August 3–8, 2025 | 📍 Knoxville, Tennessee In response to o

As part of the Evergreen Phage Meeting, Phages for Global Health is organizing a pre-conference workshop on phage purification technologies. It will include six experts giving short presentations on different purification techniques that c

Looking for lytic phage against Streptococcus mutans strains NLML9, N66, and/or UA159. Bonus points if for a lytic phage against Streptococcus gordonii DL1! Thanks so much! — Amelia Schmidt

Phage Australia at Westmead Health Precinct is hosting a course called Phage Therapy 101 for Healthcare Professionals on Nov 14, 2025, aiming to equip prescribers with practical know-how for safe, genomics-guided phage therapy.

Recent microbiology graduate applying to graduate schools. Looking for programs focusing on ABR pathogens and/or molecular phage biology. Would greatly appreciate a chance to chat about opportunities in the field. Thanks! — Ivan

Marina Mahler (University of Otago) and colleagues published a new paper on arabinosyl-hydroxy-cytosine DNA modifications, showing that these modifications enable phages to evade DNA-targeting CRISPR-Cas and restriction systems while remain

Per Kristian Thorén Edvardsen (Norwegian University of Life Sciences) and colleagues published a new paper on a cryptic prophage endolysin with muramidase activity. They solve its crystal structure and show 10,000-fold higher activity than

Xiang Hou (Shanghai Jiao Tong University School of Medicine) and colleagues published a new paper on gut phage-induced macrophage reprogramming, showing phages epigenetically prime macrophages via IL-10 to generate LPS-tolerant innate memor

Xiang Hou (Jiangsu Academy of Agricultural Sciences, China) and colleagues published a new paper on a repressor, RptR, that controls Type I restriction modification system defence islands. They show that RptR binds TAGCTA repeats to silence

Is passion enough for to keep our industry going? Jennifer Leeds (ex-Novartis; one of the microbiologists who had to help shut down Novartis’ infectious disease department) published a new perspective on antibiotic R&D talent drain, sharing

Review by Choudhary, Bankole, McDuffee, Parajuli, Poudel, Balogh, Paret and Jones in Viruses on bacteriophages as biocontrol agents against plant bacterial diseases, as an alternative to antibiotics. It discusses barriers to implementation

Free one-day Phage Therapy Workshop, "State of the art and future prospects", on Tuesday, November 25, 2025 at The Spine Building, Liverpool; registration is required. Three sessions cover phage therapy across the globe, the next generation

"It still doesn't happen overnight — the paperwork itself, I aged like 20 years." Dr. Marisa Azad shares the real timeline and logistics behind Canada's first bone infection phage therapy case, plus why her N-of-1 approach creates a platfor

The 9th International Conference on Bacteriology and Microbiology 2025 is a globally recognized scientific event bringing together researchers, microbiologists, healthcare professionals, and industry experts to explore the latest advancemen

The American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA) are hosting the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation, taking place on January 28-30, 2026. The conference aims

Precisio Biotix Therapeutics and the Mayo Clinic have announced their first patient dosed with ClyO staph lysin for multidrug-resistant prosthetic joint infection treatment.

Iddo Weiner (BiomX Ltd) and colleagues published a new paper on their nebulized phage cocktail for cystic fibrosis, showing BX004-A met safety endpoints and demonstrated potential reduction in P. aeruginosa sputum burden in first-in-human t